CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B952. A total of 4 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $261,440 | -39.3% | 9,500 | -25.2% | 0.00% | 0.0% |
| Q2 2023 | $430,911 | +17.4% | 12,700 | +24.5% | 0.00% | 0.0% |
| Q1 2023 | $366,996 | -89.7% | 10,200 | -87.3% | 0.00% | -87.5% |
| Q4 2022 | $3,570,057 | +63.0% | 80,100 | +2.8% | 0.01% | +100.0% |
| Q3 2022 | $2,190,000 | -13.5% | 77,900 | -17.0% | 0.00% | 0.0% |
| Q2 2022 | $2,532,000 | +4.0% | 93,900 | +31.3% | 0.00% | +100.0% |
| Q1 2022 | $2,435,000 | -28.3% | 71,500 | -18.7% | 0.00% | -33.3% |
| Q4 2021 | $3,396,000 | -26.5% | 87,900 | +2.7% | 0.00% | -40.0% |
| Q3 2021 | $4,622,000 | +91.9% | 85,600 | +18.9% | 0.01% | +66.7% |
| Q2 2021 | $2,408,000 | -6.3% | 72,000 | -42.3% | 0.00% | -25.0% |
| Q1 2021 | $2,571,000 | +102.8% | 124,800 | +72.4% | 0.00% | +100.0% |
| Q4 2020 | $1,268,000 | +466.1% | 72,400 | +379.5% | 0.00% | +100.0% |
| Q3 2020 | $224,000 | -20.3% | 15,100 | -30.1% | 0.00% | 0.0% |
| Q2 2020 | $281,000 | +451.0% | 21,600 | -10.0% | 0.00% | – |
| Q3 2019 | $51,000 | +363.6% | 24,000 | +500.0% | 0.00% | – |
| Q2 2019 | $11,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,696,000 | 0.16% |
| GROUP ONE TRADING, L.P. | 93,900 | $2,532,000 | 0.00% |
| SIMPLEX TRADING, LLC | 87,400 | $2,356,000 | 0.00% |
| JANE STREET GROUP, LLC | 200,900 | $5,416,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |